Evotec SE (EVO) Retained Earnings (2009 - 2026)
Evotec SE (EVO) reported Retained Earnings of $1.7 million for Q1 2026, up 11.46% on a YoY basis from $1.5 million in Q1 2025, and up 0.61% sequentially from $1.7 million in Q4 2025.
Evotec SE (EVO) Retained Earnings (2009 - 2026) Analysis & Trends
Evotec SE (EVO) has 9 years of Retained Earnings data on file, last reported at $1.7 million in Q1 2026.
- For the quarter ending Q1 2026, Retained Earnings rose 11.46% year-over-year to $1.7 million; the trailing twelve-month figure through Mar 2026 stood at $1.7 million (up 11.46% YoY), and the FY2025 full-year result was $1.7 million, down 99.89% from the prior year.
- Retained Earnings improved to $1.7 million in Q1 2026, from $1.7 million in the prior quarter.
- In the past five years, Retained Earnings ranged from a high of $1.6 billion in Q4 2023 to a low of $1.4 million in Q3 2022.
- A 5-year average of $417.8 million and a median of $1.7 million in 2025 frame the typical range for Retained Earnings.
- Across the five-year window, Retained Earnings soared 693.41% in 2022 and sank 99.89% in 2025, its largest moves.
- Tracing EVO's Retained Earnings over 5 years: stood at $1.5 billion in 2022, then advanced by 6.17% to $1.6 billion in 2023, then declined by 0.34% to $1.6 billion in 2024, then slumped by 99.89% to $1.7 million in 2025, then grew by 0.61% to $1.7 million in 2026.
- Business Quant data shows EVO's Retained Earnings at $1.7 million in Q1 2026, $1.7 million in Q4 2025, and $1.7 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | 37.04 Bn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 28.20 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 1.11 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 4.54 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 8.83 Bn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | -1.81 Bn |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 18.66 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 589.60 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | -2.13 Bn |
| 10 | Evotec SE | 351.60 Mn | 351.08 Mn | - | 1.71 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.71 Mn |
| Dec 31, 2025 | 1.70 Mn |
| Sep 30, 2025 | 1.71 Mn |
| Jun 30, 2025 | 1.65 Mn |
| Mar 31, 2025 | 1.53 Mn |
| Dec 31, 2024 | 1.55 Bn |
| Sep 30, 2024 | 1.59 Mn |
| Dec 31, 2023 | 1.56 Bn |
| Dec 31, 2022 | 1.47 Bn |
| Sep 30, 2022 | 1.45 Mn |
| Mar 31, 2022 | 1.61 Mn |
| Dec 31, 2021 | -247.58 Mn |
| Sep 30, 2021 | 1.22 Mn |
| Dec 31, 2020 | -515.83 Mn |
| Sep 30, 2010 | -797,917.39 |
| Jun 30, 2010 | -789,128.24 |
| Mar 31, 2010 | -858.78 |
| Dec 31, 2009 | -913,956.72 |